Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT04377152
NCT04377152Approved For MarketingNot Applicable

Expanded Access: 68Gallium-PSMA-11 for PET Imaging of Prostate Cancer

University of California, San Francisco1 site in 1 countryStarted: May 7, 2020Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Approved For Marketing
Locations
1
Study OverviewEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This expanded access protocol provides eligible participants with investigational 68Ga-PSMA-11 PET imaging to detect and localize prostate cancer for initial and subsequent treatment strategy.

Study Design

Study Type
Expanded Access

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age ≥ 18 years
  • •Histopathologically confirmed or biopsy proven prostate adenocarcinoma.
  • •Concern for metastatic disease in one of the following settings:
  • •Initial staging with intermediate to high risk prostate cancer.
  • •Biochemical recurrence after initial therapy.
  • •Ability to understand a written informed consent document, and the willingness to sign it

Exclusion Criteria

  • •Unlikely to comply with protocol procedures, restrictions and requirements and judged by the Investigator to be unsuitable for participation

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Thomas Hope

Principal Investigator

University of California, San Francisco

Study Sites (1)

Loading locations...

Similar Trials

Approved For Marketing
Not Applicable
Expanded Access Protocol of 68Ga-PSMA-11 for PET ImagingProstate Cancer
NCT04348682Jonsson Comprehensive Cancer Center
No Longer Available
Not Applicable
Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate CancerProstate Adenocarcinoma
NCT05415228Morand Piert, MD
No Longer Available
Not Applicable
Expanded Access [Ga-68] PSMA-11 PET ImagingProstate Cancer
NCT04800068Mayo Clinic
Completed
Phase 3
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate CancerCastration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
NCT05547386Mayo Clinic163
No Longer Available
Not Applicable
68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)Prostatic Neoplasms, Castration-ResistantProstatic Neoplasms
NCT04854369Tulane University